Published in Medical Device Business Week, June 18th, 2008
"Cancer-specific survival (CSS) was estimated using the Kaplan-Meier method. More patients treated with NSS had a solitary kidney than those undergoing RN (six, 23%, vs none, P<...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.